These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1079 related items for PubMed ID: 19942741
21. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Tabarsi P, Chitsaz E, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Amiri M, Mansouri D, Masjedi MR, Velayati AA, Caminero JA. Microb Drug Resist; 2010 Mar; 16(1):81-6. PubMed ID: 20192820 [Abstract] [Full Text] [Related]
22. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011. Nguyen HB, Nguyen NV, Tran HT, Nguyen HV, Bui QT. Western Pac Surveill Response J; 2016 Mar; 7(2):35-40. PubMed ID: 27508089 [Abstract] [Full Text] [Related]
23. Extensively drug-resistant tuberculosis in the United States, 1993-2007. Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP. JAMA; 2008 Nov 12; 300(18):2153-60. PubMed ID: 19001626 [Abstract] [Full Text] [Related]
24. Management of multidrug resistant tuberculosis. Daley CL, Caminero JA. Semin Respir Crit Care Med; 2013 Feb 12; 34(1):44-59. PubMed ID: 23460005 [Abstract] [Full Text] [Related]
25. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis. Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A. Int J Tuberc Lung Dis; 2012 Sep 12; 16(9):1228-33. PubMed ID: 22748131 [Abstract] [Full Text] [Related]
26. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China. Alene KA, Yi H, Viney K, McBryde ES, Yang K, Bai L, Gray DJ, Clements ACA, Xu Z. BMC Infect Dis; 2017 Aug 16; 17(1):573. PubMed ID: 28814276 [Abstract] [Full Text] [Related]
27. Extensively drug-resistant tuberculosis: current challenges and threats. Jain A, Mondal R. FEMS Immunol Med Microbiol; 2008 Jul 16; 53(2):145-50. PubMed ID: 18479439 [Abstract] [Full Text] [Related]
28. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region. Porwal C, Kaushik A, Makkar N, Banavaliker JN, Hanif M, Singla R, Bhatnagar AK, Behera D, Pande JN, Singh UB. PLoS One; 2013 Jul 16; 8(2):e55299. PubMed ID: 23390524 [Abstract] [Full Text] [Related]
32. [Epidemiology of drug-resistant tuberculosis: world--Europe--Poland]. Jagielski T, Augustynowicz-Kopeć E, Zwolska Z. Wiad Lek; 2010 Jul 16; 63(4):345-57. PubMed ID: 21612049 [Abstract] [Full Text] [Related]
33. Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand. Roongruangpitayakul C, Chuchottaworn C. J Med Assoc Thai; 2013 Oct 16; 96(10):1273-82. PubMed ID: 24350407 [Abstract] [Full Text] [Related]
34. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC, SMIRA/TBNET Study Group. Eur Respir J; 2007 Oct 16; 30(4):623-6. PubMed ID: 17690121 [Abstract] [Full Text] [Related]
37. Extensively drug resistant tuberculosis (XDR-TB) in Chest Disease Institute, 1997-2005. Chuchottaworn C. J Med Assoc Thai; 2010 Jan 16; 93(1):34-7. PubMed ID: 20196408 [Abstract] [Full Text] [Related]
40. Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre. Liao S, Cai C, Huo FM, Wu JN, Kong CC, Huang HR, Xu SF, Sun ZG. Int J Tuberc Lung Dis; 2017 Sep 01; 21(9):990-995. PubMed ID: 28826447 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]